|
Genomic DNA products from Multidrug-Resistant Candida auris
Candida auris is an emerging multidrug-resistant pathogenic yeast that causes invasive infections and outbreaks in nosocomial settings, resulting in high mortality. First identified in 2009, this pathogen has now been isolated in over sixty countries across six continents 1,2. Unlike other Candida species, C. auris demonstrates a unique ability to colonize the skin, persist on surfaces for prolonged periods, and spread efficiently within healthcare facilities. The Centers for Disease Control and Prevention (CDC) classified C. auris as an urgent threat in 2019. 3 Clinical isolates from a hospital in Pakistan, the site of a 2014 C. auris outbreak 5, and newly released genomic DNA products listed below are available in BEI Resources. These materials represent bloodstream infections with varied antifungal resistance profiles to azole and polyene drug classes. More information about the resistance profiles of the isolates from which these reagents are derived (NR-52713 and NR-52714) is available in the BEI Resources Antimicrobial Database and on the individual product web pages and documentation.
|
BEI Item No.
|
Description
|
| NR-53766 |
Genomic DNA from Candida auris, Strain AKU-2017-385 Candida auris |
| NR-53767 |
Genomic DNA from Candida auris, Strain AKU-2018-257 Candida auris |
_330X660.jpg)
References:
1. Forsberg, K., et al. “Candida auris: The Recent Emergence of a Multidrug-Resistant Fungal Pathogen.” Med. Mycol. 57 (2019): 1-12. PubMed: 30085270.
2. Jenks, J., E. H. Tobin, and F. Zahra. “Candida auris.” In: StatPearls [Internet]. Florida: Treasure Island: StatPearls Publishing, 2025. <https://www.ncbi.nlm.nih.gov/books/NBK563297/>
3. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, U.S. Department of Health and Human Services: Atlanta, GA, 2019; www.cdc.gov/DrugResistance/Biggest-Threats.html. Accessed 26 February 2026.
4. Sayeed, M. A., et al. “Clinical Spectrum and Factors Impacting Outcome of Candida auris: A Single Center Study from Pakistan.” BMC Infect. Dis. 19 (2019): 384. PubMed: 31060514.
Image Alt Text: A. Globose yeast cells in Gram’s staining; B. C. auris growth on CHROMagar. Credit: Dharmendra Kumar, Tuhina Banerjee, Chandra Bhan Pratap, and Ragini Tilak (D. Kumar et al/CC BY 4.0)
Image Credit: Globose yeast cells in Gram’s staining and C. auris growth. (D. Kumar et al/CC BY 4.0)
|